Detalls del projecte
Descripció
Funded by the Marie Skłodowska-Curie Actions programme, the TOLERATE project will provide training in the development of innovative strategies for autoimmune disease treatment to bring novel therapeutic agents to the market. The objective is to introduce innovative tolerogenic therapies for the treatment of autoimmune diseases using cell therapy, nanotechnology and protein-engineered tolerogenic vaccines to re-establish immune tolerance. The TOLERATE platform will provide eight doctoral candidates with unique interdisciplinary clinical skills together with additional training in ethical, regulatory and legal aspects in the development of therapeutics and diagnostics for autoimmune diseases.
| Acrònim | TOLERATE |
|---|---|
| Estatus | Actiu |
| Data efectiva d'inici i finalització | 1/10/22 → 30/09/26 |
Socis col·laboradors
- Katholieke Universiteit Leuven (Coordinador) (guia)
- Stichting Sanquin Bloedvoorziening (Soci del projecte)
- Semmelweis University (Soci del projecte)
- Assistance publique - Hôpitaux de Paris (Soci del projecte)
- Royal College of Surgeons in Ireland (Soci del projecte)
- Helmholtz-Zentrum Dresden-Rossendorf (Soci del projecte)
- Anicells (Soci del projecte)
Finançament
- Comissió Europea (CE)
- MSCA Doctoral Network
Fingerprint
Explora els temes de recerca tractats en aquest projecte. Les etiquetes es generen en funció dels ajuts rebuts. Juntes formen un fingerprint únic.